Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.5799
-0.0301 (-4.93%)
Mar 31, 2025, 10:01 AM EDT - Market open
Harvard Bioscience Employees
As of December 31, 2024, Harvard Bioscience had 355 total employees, including 330 full-time and 25 part-time employees. The number of employees decreased by 61 or -14.66% compared to the previous year.
Employees
355
Change (1Y)
-61
Growth (1Y)
-14.66%
Revenue / Employee
$265,169
Profits / Employee
-$34,944
Market Cap
25.56M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
HBIO News
- 18 days ago - Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025 - GlobeNewsWire
- 18 days ago - Harvard Bioscience, Inc. (HBIO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting - GlobeNewsWire
- 4 weeks ago - Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET - GlobeNewsWire
- 2 months ago - Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference - GlobeNewsWire
- 5 months ago - Harvard Bioscience, Inc. (HBIO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET - GlobeNewsWire